Existing evidence has revealed that various enzymes are dysregulated in AD, which is involved in the cleavage of amyloid precursor protein (APP) and tau hyperphosphorylation, resulting in increased levels of amyloid-β and tau fibrils in neurons and, ultimately, neurodegeneration. Here, MAPT is linked to Alzheimer disease.